US drugmaker Novo Nordisk sued Hims & Hers for selling unapproved weight-loss drugs Novo Nordisk warns of high impurity levels in Hims’ injectable and oral formulations FDA and medical bodies advise against unapproved compounded GLP-1 drugs for safety reasons
